Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 58,800 KRW
Change Today -600.00 / -1.01%
Volume 109.0K
As of 2:10 AM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

lg life sciences ltd (068870) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/7/15 - 91,100
52 Week Low
09/12/14 - 32,600
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for LG LIFE SCIENCES LTD (068870)

Related News

No related news articles were found.

lg life sciences ltd (068870) Related Businessweek News

No Related Businessweek News Found

lg life sciences ltd (068870) Details

LG Life Sciences Co, Ltd. researches, develops, produces, and commercializes pharmaceuticals, animal health products, and specialty chemicals in South Korea and internationally. The company’s pharmaceutical products include fertility treatment related products, products for hormones, viscosupplements, facial aesthetics, vaccines, chemicals, and other HA products. It also provides veterinary medicine, such as milk production enhancement products for dairy and beef cows in lactation; and crop protection products, such as insecticides, fungicides, herbicides, and pest management products. In addition, the company offers diagnostics products comprise ELISA kits; Real-time PCR kits; GenoBlot kits; and allergy screening systems, as well as intermediaries and active pharmaceutical ingredients. LG Life Sciences, Ltd. is headquartered in Seoul, South Korea.

lg life sciences ltd (068870) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

lg life sciences ltd (068870) Key Developments

LG Life Sciences, Ltd., Annual General Meeting, Mar 13, 2015

LG Life Sciences, Ltd., Annual General Meeting, Mar 13, 2015., at 10:00 Korea Standard Time. Location: 58 LG Gwanghwamun Building basement t. Agenda: To consider the earnings results for the year ended December 31, 2014; to consider the appointment of directors; and to consider the approval of remuneration of directors.

LG Life Sciences, Ltd. Presents at Korea Investor Conference 2015, Mar-04-2015 through Mar-06-2015

LG Life Sciences, Ltd. Presents at Korea Investor Conference 2015, Mar-04-2015 through Mar-06-2015. Venue: Conrad Hotel, Yeouido, Seoul, South Korea. Presentation Date(s): Mar-04-2015.

LG Life Sciences Enters Agreement with Weijian Pharma to Market Fertility Treatment Follitrope in China

LG Life Sciences has entered an agreement granting Weijian Pharma exclusive rights to sell ovulation-induction medication Follitrope (recombinant follitropin (FSH)) in China. Follitrope is used to increase follicle-stimulating hormones and stimulate the ovaries, to increase the chances of conceiving.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
068870:KS 58,800.00 KRW -600.00

068870 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 068870.
View Industry Companies

Industry Analysis


Industry Average

Valuation 068870 Industry Range
Price/Earnings 100.0x
Price/Sales 2.2x
Price/Book 3.8x
Price/Cash Flow 149.7x
TEV/Sales 1.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LG LIFE SCIENCES LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at